SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) — all Canadian products
85 DINs
79 marketed/approved
1 in shortage
Every Health Canada Drug Identification Number whose active ingredient is SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02428296 | APO-SITAGLIPTIN | APOTEX INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 100 MG | Marketed | |
| 02428261 | APO-SITAGLIPTIN | APOTEX INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 25 MG | Marketed | |
| 02428288 | APO-SITAGLIPTIN | APOTEX INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG | Marketed | |
| 02435780 | APO-SITAGLIPTIN-METFORMIN | APOTEX INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 850 MG | Marketed | |
| 02435772 | APO-SITAGLIPTIN-METFORMIN | APOTEX INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 500 MG | Marketed | |
| 02435799 | APO-SITAGLIPTIN-METFORMIN | APOTEX INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 1000 MG | Marketed | |
| 02506297 | APO-SITAGLIPTIN/METFORMIN XR | APOTEX INC | Tablet (Extended-Release) | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 100 MG; METFORMIN HYDROCHLORIDE 1000 MG | Marketed | |
| 02506270 | APO-SITAGLIPTIN/METFORMIN XR | APOTEX INC | Tablet (Extended-Release) | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 500 MG | Marketed | |
| 02506289 | APO-SITAGLIPTIN/METFORMIN XR | APOTEX INC | Tablet (Extended-Release) | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 1000 MG | Marketed | |
| 02333872 | JANUMET | MERCK CANADA INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 1000 MG | Marketed | |
| 02333856 | JANUMET | MERCK CANADA INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 500 MG | Marketed | |
| 02416808 | JANUMET XR | MERCK CANADA INC | Tablet (Extended-Release) | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 100 MG; METFORMIN HYDROCHLORIDE 1000 MG | Marketed | |
| 02416786 | JANUMET XR | MERCK CANADA INC | Tablet (Extended-Release) | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 500 MG | Marketed | |
| 02416794 | JANUMET XR | MERCK CANADA INC | Tablet (Extended-Release) | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 1000 MG | Marketed | |
| 02303922 | JANUVIA | MERCK CANADA INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 100 MG | Marketed | |
| 02388847 | JANUVIA | MERCK CANADA INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG | Marketed | |
| 02388839 | JANUVIA | MERCK CANADA INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 25 MG | Marketed | |
| 02534991 | M-SITAGLIPTIN | MANTRA PHARMA INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG | Marketed | |
| 02535009 | M-SITAGLIPTIN | MANTRA PHARMA INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 100 MG | Marketed | |
| 02534983 | M-SITAGLIPTIN | MANTRA PHARMA INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 25 MG | Marketed | |
| 02570629 | M-SITAGLIPTIN-METFORMIN | MANTRA PHARMA INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 1000 MG | Approved | |
| 02570602 | M-SITAGLIPTIN-METFORMIN | MANTRA PHARMA INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 500 MG | Approved | |
| 02570610 | M-SITAGLIPTIN-METFORMIN | MANTRA PHARMA INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 850 MG | Approved | |
| 02558165 | NAT-SITAGLIPTIN | NATCO PHARMA (CANADA) INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG | Marketed | |
| 02558157 | NAT-SITAGLIPTIN | NATCO PHARMA (CANADA) INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 25 MG | Marketed | |
| 02543400 | NAT-SITAGLIPTIN | NATCO PHARMA (CANADA) INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 100 MG | Marketed | |
| 02558823 | NB-SITAGLIPTIN | NB PHARMA INC. | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG | Approved | |
| 02558831 | NB-SITAGLIPTIN | NB PHARMA INC. | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 100 MG | Approved | |
| 02558807 | NB-SITAGLIPTIN | NB PHARMA INC. | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 25 MG | Approved | |
| 02559641 | NB-SITAGLIPTIN-METFORMIN | NB PHARMA INC. | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 850 MG | Approved | |
| 02559633 | NB-SITAGLIPTIN-METFORMIN | NB PHARMA INC. | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 500 MG | Approved | |
| 02559668 | NB-SITAGLIPTIN-METFORMIN | NB PHARMA INC. | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 1000 MG | Approved | |
| 02566168 | NRA-SITAGLIPTIN TABLETS | NORA PHARMA INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG | Approved | |
| 02566141 | NRA-SITAGLIPTIN TABLETS | NORA PHARMA INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 25 MG | Approved | |
| 02566176 | NRA-SITAGLIPTIN TABLETS | NORA PHARMA INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 100 MG | Approved | |
| 02566311 | NRA-SITAGLIPTIN/METFORMIN | NORA PHARMA INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 1000 MG | Approved | |
| 02566303 | NRA-SITAGLIPTIN/METFORMIN | NORA PHARMA INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 850 MG | Approved | |
| 02566281 | NRA-SITAGLIPTIN/METFORMIN | NORA PHARMA INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 500 MG | Approved | |
| 02503867 | PMS-SITAGLIPTIN | PHARMASCIENCE INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 100 MG | Marketed | |
| 02503859 | PMS-SITAGLIPTIN | PHARMASCIENCE INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG | Marketed | |
| 02503840 | PMS-SITAGLIPTIN | PHARMASCIENCE INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 25 MG | Marketed | |
| 02553384 | PRO-SITAGLIPTIN | PRO DOC LIMITEE | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG | Marketed | |
| 02553392 | PRO-SITAGLIPTIN | PRO DOC LIMITEE | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 100 MG | Marketed | |
| 02553376 | PRO-SITAGLIPTIN | PRO DOC LIMITEE | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 25 MG | Marketed | |
| 02552833 | PRO-SITAGLIPTIN-METFORMIN | PRO DOC LIMITEE | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 1000 MG | Marketed | |
| 02552817 | PRO-SITAGLIPTIN-METFORMIN | PRO DOC LIMITEE | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 500 MG | Marketed | |
| 02552825 | PRO-SITAGLIPTIN-METFORMIN | PRO DOC LIMITEE | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 850 MG | Marketed | |
| 02545845 | PRZ-SITAGLIPTIN | PHARMARIS CANADA INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG | Marketed | |
| 02545853 | PRZ-SITAGLIPTIN | PHARMARIS CANADA INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 100 MG | Marketed | |
| 02545837 | PRZ-SITAGLIPTIN | PHARMARIS CANADA INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 25 MG | Marketed | |
| 02552310 | PRZ-SITAGLIPTIN-METFORMIN | PHARMARIS CANADA INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 850 MG | Marketed | |
| 02552302 | PRZ-SITAGLIPTIN-METFORMIN | PHARMARIS CANADA INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 500 MG | Approved | |
| 02552329 | PRZ-SITAGLIPTIN-METFORMIN | PHARMARIS CANADA INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 1000 MG | Marketed | |
| 02545675 | RIVA SITAGLIPTIN/METFORMIN | LABORATOIRE RIVA INC. | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 1000 MG | Approved | |
| 02545667 | RIVA SITAGLIPTIN/METFORMIN | LABORATOIRE RIVA INC. | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 500 MG | Approved | |
| 02504065 | SANDOZ SITAGLIPTIN | SANDOZ CANADA INCORPORATED | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 100 MG | Marketed | |
| 02504057 | SANDOZ SITAGLIPTIN | SANDOZ CANADA INCORPORATED | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG | Marketed | |
| 02504049 | SANDOZ SITAGLIPTIN | SANDOZ CANADA INCORPORATED | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 25 MG | Marketed | |
| 02503956 | SANDOZ SITAGLIPTIN-METFORMIN | SANDOZ CANADA INCORPORATED | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 500 MG | Marketed | |
| 02503972 | SANDOZ SITAGLIPTIN-METFORMIN | SANDOZ CANADA INCORPORATED | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 1000 MG | Marketed | |
| 02503964 | SANDOZ SITAGLIPTIN-METFORMIN | SANDOZ CANADA INCORPORATED | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 850 MG | Marketed | |
| 02529114 | SANDOZ SITAGLIPTIN-METFORMIN XR | SANDOZ CANADA INCORPORATED | Tablet (Extended-Release) | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 1000 MG | Marketed | |
| 02529106 | SANDOZ SITAGLIPTIN-METFORMIN XR | SANDOZ CANADA INCORPORATED | Tablet (Extended-Release) | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 500 MG | Marketed | |
| 02529122 | SANDOZ SITAGLIPTIN-METFORMIN XR | SANDOZ CANADA INCORPORATED | Tablet (Extended-Release) | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 100 MG; METFORMIN HYDROCHLORIDE 1000 MG | Marketed | |
| 02545519 | SITAGLIPTIN | LABORATOIRE RIVA INC. | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 25 MG | Approved | |
| 02558017 | SITAGLIPTIN | JUBILANT GENERICS LIMITED | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 25 MG | Approved | |
| 02558025 | SITAGLIPTIN | JUBILANT GENERICS LIMITED | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG | Approved | |
| 02558033 | SITAGLIPTIN | JUBILANT GENERICS LIMITED | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 100 MG | Approved | |
| 02529033 | SITAGLIPTIN | SIVEM PHARMACEUTICALS ULC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 25 MG | Marketed | |
| 02529041 | SITAGLIPTIN | SIVEM PHARMACEUTICALS ULC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG | Marketed | |
| 02529068 | SITAGLIPTIN | SIVEM PHARMACEUTICALS ULC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 100 MG | Marketed | Yes |
| 02548550 | SITAGLIPTIN | SANIS HEALTH INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 25 MG | Marketed | |
| 02545535 | SITAGLIPTIN | LABORATOIRE RIVA INC. | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 100 MG | Approved | |
| 02545527 | SITAGLIPTIN | LABORATOIRE RIVA INC. | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG | Approved | |
| 02548577 | SITAGLIPTIN | SANIS HEALTH INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 100 MG | Marketed | |
| 02548569 | SITAGLIPTIN | SANIS HEALTH INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG | Marketed | |
| 02529173 | SITAGLIPTIN-METFORMIN | SIVEM PHARMACEUTICALS ULC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 1000 MG | Marketed | |
| 02529165 | SITAGLIPTIN-METFORMIN | SIVEM PHARMACEUTICALS ULC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 850 MG | Marketed | |
| 02529157 | SITAGLIPTIN-METFORMIN | SIVEM PHARMACEUTICALS ULC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 500 MG | Marketed | |
| 02333864 | JANUMET | MERCK CANADA INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 850 MG | Cancelled Post Market | |
| 02532654 | PMS-SITAGLIPTIN-METFORMIN | PHARMASCIENCE INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 500 MG | Cancelled Pre Market | |
| 02532662 | PMS-SITAGLIPTIN-METFORMIN | PHARMASCIENCE INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG; METFORMIN HYDROCHLORIDE 1000 MG | Cancelled Pre Market | |
| 02526719 | RIVA SITAGLIPTIN | LABORATOIRE RIVA INC. | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 25 MG | Cancelled Pre Market | |
| 02526735 | RIVA SITAGLIPTIN | LABORATOIRE RIVA INC. | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 100 MG | Cancelled Pre Market | |
| 02526727 | RIVA SITAGLIPTIN | LABORATOIRE RIVA INC. | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG | Cancelled Pre Market |
Browse other molecules: